» Authors » Carol Armour

Carol Armour

Explore the profile of Carol Armour including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 673
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Serhal S, Krass I, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al.
J Am Pharm Assoc (2003) . 2024 Sep; 65(1):102252. PMID: 39326844
Background: Evidence-based asthma management services have been tested in Australian community pharmacies for over 2 decades and have been well received by patients but are not retained in practice. The...
2.
Lartey S, Lung T, Serhal S, Bereznicki L, Bereznicki B, Emmerton L, et al.
PLoS One . 2023 Jan; 18(1):e0279748. PMID: 36603182
Introduction: Asthma has substantial and increasing health and economic burden worldwide. This study aimed to estimate healthcare expenditure and determine the factors that increase expenditure in Australians with poorly controlled...
3.
Serhal S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, Bosnic-Anticevich S, et al.
NPJ Prim Care Respir Med . 2022 Nov; 32(1):53. PMID: 36384948
Uptake and outcomes of pharmacist-initiated general practitioner (GP) referrals for patients with poorly controlled asthma were investigated. Pharmacists referred at-risk patients for GP assessment. Patients were categorized as action takers...
4.
Serhal S, Armour C, Billot L, Krass I, Emmerton L, Saini B, et al.
Front Pharmacol . 2022 Apr; 13:869162. PMID: 35401235
Accurate clinical assessment of patient adherence using reliable and valid measures is essential in establishing the presence of adherence issues and support practices for pharmacists. This investigation aims to conduct...
5.
Serhal S, Mitchell B, Krass I, Emmerton L, Bereznicki B, Bereznicki L, et al.
Res Social Adm Pharm . 2022 Apr; 18(9):3656-3668. PMID: 35379559
Background: An evidence-based randomized controlled trial for a novel Pharmacy Asthma Service was tested in 3 Australian states. Positive asthma outcomes were achieved after the 12-month intervention, albeit in both...
6.
Serhal S, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, Bereznicki L, et al.
J Am Pharm Assoc (2003) . 2022 Mar; 62(4):1260-1269.e2. PMID: 35283066
Background: Evaluating pharmacy services from the perspective of the end user-patients-is imperative for ensuring the sustainability of services. Objectives: This study evaluated patient feedback regarding an evidence-based community pharmacist-delivered Pharmacy...
7.
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, et al.
Front Pharmacol . 2022 Jan; 12:798263. PMID: 35024035
Building on lessons learnt from evidence-based community pharmacy asthma management models, a streamlined and technology supported Pharmacy Asthma Service (PAS) was developed to promote the integration of the service into...
8.
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, et al.
Am J Pharm Educ . 2021 Aug; 86(4):8633. PMID: 34400397
To provide optimal asthma care, community pharmacists must have advanced, contemporary knowledge, and the skills to translate that knowledge into practice. The development and evaluation of an innovative multi-mode education...
9.
Webster R, Usherwood T, Joshi R, Saini B, Armour C, Critchley S, et al.
Med J Aust . 2021 Apr; 214(9):420-427. PMID: 33899216
Objectives: To determine whether a multifaceted primary health care intervention better controlled cardiovascular disease (CVD) risk factors in patients with high risk of CVD than usual care. Design, Setting: Parallel...
10.
Fathima M, Bawa Z, Mitchell B, Foster J, Armour C, Saini B
Int J Chron Obstruct Pulmon Dis . 2021 Mar; 16:519-533. PMID: 33688177
Purpose: To evaluate the effectiveness of a pilot community pharmacy care model for patients with chronic obstructive pulmonary disease (COPD) to improve: 1) inhaler technique; 2) medication adherence; and 3)...